Spectral Medical Inc. (TSX:EDT)
Canada · Delayed Price · Currency is CAD 1.390
-0.010 (-0.71%)
Jul 31, 2026, 2:33 PM EST
Spectral Medical Revenue
Spectral Medical had revenue of 891.00K CAD in the quarter ending March 31, 2026, with 55.77% growth. This brings the company's revenue in the last twelve months to 2.76M, up 26.07% year-over-year. In the year 2025, Spectral Medical had annual revenue of 2.44M with 6.82% growth.
Revenue (ttm)
2.76M
Revenue Growth
+26.07%
P/S Ratio
147.72
Revenue / Employee
95.21K
Employees
29
Market Cap
407.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.44M | 156.00K | 6.82% |
| Dec 31, 2024 | 2.29M | 688.00K | 43.05% |
| Dec 31, 2023 | 1.60M | -69.00K | -4.14% |
| Dec 31, 2022 | 1.67M | -329.00K | -16.48% |
| Dec 31, 2021 | 2.00M | -105.00K | -5.00% |
| Dec 31, 2020 | 2.10M | -767.00K | -26.74% |
| Dec 31, 2019 | 2.87M | -972.00K | -25.31% |
| Dec 31, 2018 | 3.84M | 171.00K | 4.66% |
| Dec 31, 2017 | 3.67M | 124.00K | 3.50% |
| Dec 31, 2016 | 3.55M | 456.00K | 14.76% |
| Dec 31, 2015 | 3.09M | 125.00K | 4.22% |
| Dec 31, 2014 | 2.96M | 292.00K | 10.93% |
| Dec 31, 2013 | 2.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.49B |
| Extendicare | 1.75B |
| Green Thumb Industries | 1.67B |
| Verano Holdings | 1.14B |
| Sienna Senior Living | 1.05B |
| Cresco Labs | 895.33M |
| Medical Facilities | 363.93M |
| Canopy Growth | 284.60M |
Spectral Medical News
- 5 weeks ago - Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX - GlobeNewsWire
- 7 weeks ago - Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial - GlobeNewsWire
- 2 months ago - Spectral Medical Announces PMA Submission to U.S. FDA for PMX - GlobeNewsWire
- 3 months ago - Spectral Medical Earnings release: Q1 2026 - Filings
- 3 months ago - Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference - Newsfile Corp
- 4 months ago - Spectral Medical Earnings release: Q4 2025 - Filings